NPC
AZN icon

National Planning Corporation’s AstraZeneca AZN Stock Holding History

National Planning Corporation’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-5,264
Closed -$357K – 85
2017
Q3 		$357K Sell
5,264
-2,037
-28% -$129K 0.03% 462
2017
Q2 		$495K Sell
7,301
-963
-12% -$62.9K 0.04% 410
2017
Q1 		$517K Buy
8,264
+303
+4% +$17.6K 0.04% 375
2016
Q4 		$439K Sell
7,961
-493
-6% -$28K 0.03% 405
2016
Q3 		$472K Sell
8,454
-417
-5% -$27.3K 0.04% 374
2016
Q2 		$607K Buy
8,871
+87
+1% +$5.05K 0.05% 337
2016
Q1 		$491K Sell
8,784
-476
-5% -$28.6K 0.04% 356
2015
Q4 		$556K Buy
9,260
+8
+0.1% +$525 0.05% 377
2015
Q3 		$595K Sell
9,252
-28,405
-75% -$1.87M 0.05% 309
2015
Q2 		$1.28M Buy
37,657
+18,891
+101% +$1.29M 0.12% 180
2015
Q1 		$1.26M Sell
18,766
-659
-3% -$45.8K 0.11% 175
2014
Q4 		$1.32M Sell
19,425
-104
-0.5% -$7.45K 0.09% 198
2014
Q3 		$1.36M Buy
19,529
+952
+5% +$69.7K 0.1% 193
2014
Q2 		$1.38M Buy
18,577
+573
+3% +$41.4K 0.11% 191
2014
Q1 		$1.18M Buy
18,004
+1,659
+10% +$107K 0.1% 204
2013
Q4 		$968K Buy
16,345
+5,017
+44% +$273K 0.09% 232
2013
Q3 		$588K Buy
11,328
+4,158
+58% +$209K 0.06% 318
2013
Q2 		$340K Buy
+7,170
New +$365K 0.04% 358

Other funds holding AZN

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
EIP
Epoch Investment Partners New York $16.5B AUM 24.3% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

National Planning Corporation's AZN Position: Q4 2017 in Review

National Planning Corporation sold out of AstraZeneca (AZN) in Q4 2017, closing a stake of 5,264 shares — an estimated $357K sold.

National Planning Corporation first reported a position in AZN in Q2 2013 and held it in 18 quarters. The position peaked at $1.38M in Q2 2014. 503 funds tracked by Wall St. Rank hold AZN as of Q4 2017.

  • National Planning Corporation reported no remaining AstraZeneca position as of Q4 2017 after selling out during the quarter.
  • National Planning Corporation sold 5,264 AstraZeneca shares in Q4 2017, an estimated $357K.
  • National Planning Corporation first reported a position in AstraZeneca in Q2 2013 and held it in 18 quarters.
  • National Planning Corporation's AstraZeneca position peaked at $1.38M in Q2 2014.
  • 503 funds tracked by Wall St. Rank held AstraZeneca as of Q4 2017.

Based on National Planning Corporation's 13F filing for Q4 2017, filed 14 Feb 2018.